Ledger.Open graph →

SEC Form D · filed December 9, 2020

Genesis Therapeutics, Inc

Offering

—

Sold

$49.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BURLINGAME, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Evan Feinberg · BURLINGAME, CAExec · Director Kris Jenner · BURLINGAME, CADirector Peptiboon Prasit · BURLINGAME, CADirector Benjamin Sklaroff · BURLINGAME, CAExec Leonard Bell · BURLINGAME, CADirector Michael Berolzheimer · SAN FRANCISCO, CAExec Edward C. Hamburg · LARAMIE, WYExec · Director Bee Partners Iv GP, LLC · SAN FRANCISCO, CADirector Shane C. Schulz · LARAMIE, WYDirector Rob Schultz · LARAMIE, WYDirector Nicholas Stock · BURLINGAME, CAExec Edward Schulak · Cambridge, MAExec · Director David Sinclair · Cambridge, MADirector Carlos Bustamante · Cambridge, MADirector Space Angels LLC · New York, NYDirector Paul H. Finnen · Jackson, WYExec Nicholas Stock · BURLINGAME, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗